Last reviewed · How we verify

NCT06953518

An Open-Label Pilot Study of Qualia Senolytic Supplementation for the Attenuation of Systemic Inflammatory Cytokines

Not yet recruiting NA Last updated 1 May 2025
What this trial tests

NA trial testing Qualia Senolytic in Inflammation in 40 participants. Not yet recruiting.

Timeline
12 May 2025
Primary endpoint
18 May 2025
18 May 2025

Quick facts

Lead sponsorQualia Life Sciences
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment40
Start date12 May 2025
Primary completion18 May 2025
Estimated completion18 May 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Qualia Life Sciences

Who can join

Adults 45 to 79, any sex, with Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This open-label pilot study includes adults aged 45 to 79 residing in the United States. The study will last 7 days. Participants will provide blood samples via an at-home finger-prick kit at baseline and day 7 and complete electronic surveys on health indicators at baseline, and days 3 and 7. All procedures are conducted remotely, with no in-person visits, to collect real-world evidence.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exploratory Effects of a Novel Nutraceutical on Senescence-Related Protein Biomarkers in Healthy Adults: A Pilot Proteomics Study.
    Blomquist SA, Kelly G, D'Adamo CR, Han C, et al · · 2026 · PMID 42196384 · DOI 10.3390/ijms27104406

Verify or expand the search:

Other recruiting trials for Inflammation

Currently open trials in the same condition.

Other Qualia Life Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06953518.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing